Literature DB >> 3278902

Sialylated lactosylceramides. Possible inducers of non-specific immunosuppression and atherosclerotic lesions.

N V Prokazova1, E V Dyatlovitskaya, L D Bergelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278902     DOI: 10.1111/j.1432-1033.1988.tb13847.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


× No keyword cloud information.
  7 in total

1.  Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.

Authors:  J W Chu; F J Sharom
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

Review 2.  Gangliosides and antitumor immunity.

Authors:  L D Bergelson
Journal:  Clin Investig       Date:  1993-08

3.  Significant inhibition of hybridoma cells by exogenous application of ganglioside GM3, a possible modulator of cell growth in vitro.

Authors:  H Brandt; J Müthing; J Peter-Katalinić; J Lehmann
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Gangliosides are potent immunosuppressors of IL-2-mediated T-cell proliferation in a low protein environment.

Authors:  P Lu; F J Sharom
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

5.  Biochemical characterization of Campylobacter fetus lipopolysaccharides.

Authors:  A P Moran; D T O'Malley; T U Kosunen; I M Helander
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

6.  Enhancing of GM3 synthase expression during differentiation of human blood monocytes into macrophages as in vitro model of GM3 accumulation in atherosclerotic lesion.

Authors:  Elena V Gracheva; Nelya N Samovilova; Natalia K Golovanova; Svetlana V Kashirina; Alexander Shevelev; Igor Rybalkin; Tat'yana Gurskaya; Tat'yana N Vlasik; Elena R Andreeva; Nina V Prokazova
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

Review 7.  Therapeutic potential and challenges of natural killer cells in treatment of solid tumors.

Authors:  Andrea Gras Navarro; Andreas T Björklund; Martha Chekenya
Journal:  Front Immunol       Date:  2015-04-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.